APOE and immunity: Research highlights

INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in...

Full description

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 19; no. 6; pp. 2677 - 2696
Main Authors Kloske, Courtney M., Barnum, Christopher J., Batista, Andre F., Bradshaw, Elizabeth M., Brickman, Adam M., Bu, Guojun, Dennison, Jessica, Gearon, Mary D., Goate, Alison M., Haass, Christian, Heneka, Michael T., Hu, William T., Huggins, Lenique K. L., Jones, Nahdia S., Koldamova, Radosveta, Lemere, Cynthia A., Liddelow, Shane A., Marcora, Edoardo, Marsh, Samuel E., Nielsen, Henrietta M., Petersen, Kellen K., Petersen, Melissa, Piña‐Escudero, Stefanie D., Qiu, Wei Qiao, Quiroz, Yakeel T., Reiman, Eric, Sexton, Claire, Tansey, Malú Gámez, TCW, Julia, Teunissen, Charlotte E., Tijms, Betty M., Kant, Rik, Wallings, Rebecca, Weninger, Stacie C., Wharton, Whitney, Wilcock, Donna M., Wishard, Tyler James, Worley, Susan L, Zetterberg, Henrik, Carrillo, Maria C.
Format Journal Article
LanguageEnglish
Published United States 01.06.2023
Subjects
Online AccessGet full text
ISSN1552-5260
1552-5279
1552-5279
DOI10.1002/alz.13020

Cover

Abstract INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODS The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTS During the 4‐day meeting, presenters illuminated aspects of the cross‐talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). DISCUSSION This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
AbstractList INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODS The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTS During the 4‐day meeting, presenters illuminated aspects of the cross‐talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). DISCUSSION This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.METHODSThe meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).RESULTSDuring the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.DISCUSSIONThis manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODSThe meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTSDuring the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor alpha [TNF alpha]). DISCUSSIONThis manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
INTRODUCTION:  At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene ( APOE ) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias. METHODS:  The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry. RESULTS:  During the 4-day meeting, presenters illuminated aspects of the cross-talk between  APOE  and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]). DISCUSSION:  This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
Author Petersen, Kellen K.
TCW, Julia
Lemere, Cynthia A.
Weninger, Stacie C.
Tansey, Malú Gámez
Barnum, Christopher J.
Batista, Andre F.
Brickman, Adam M.
Huggins, Lenique K. L.
Tijms, Betty M.
Sexton, Claire
Jones, Nahdia S.
Teunissen, Charlotte E.
Koldamova, Radosveta
Piña‐Escudero, Stefanie D.
Dennison, Jessica
Bu, Guojun
Marcora, Edoardo
Wallings, Rebecca
Carrillo, Maria C.
Marsh, Samuel E.
Worley, Susan L
Goate, Alison M.
Reiman, Eric
Wishard, Tyler James
Hu, William T.
Nielsen, Henrietta M.
Haass, Christian
Zetterberg, Henrik
Qiu, Wei Qiao
Wharton, Whitney
Liddelow, Shane A.
Petersen, Melissa
Bradshaw, Elizabeth M.
Gearon, Mary D.
Wilcock, Donna M.
Kloske, Courtney M.
Quiroz, Yakeel T.
Heneka, Michael T.
Kant, Rik
Author_xml – sequence: 1
  givenname: Courtney M.
  surname: Kloske
  fullname: Kloske, Courtney M.
  email: cmkloske@alz.org
  organization: Alzheimer's Association
– sequence: 2
  givenname: Christopher J.
  surname: Barnum
  fullname: Barnum, Christopher J.
  organization: INmune Bio, Inc
– sequence: 3
  givenname: Andre F.
  surname: Batista
  fullname: Batista, Andre F.
  organization: Harvard Medical School
– sequence: 4
  givenname: Elizabeth M.
  surname: Bradshaw
  fullname: Bradshaw, Elizabeth M.
  organization: Columbia University Irving Medical Center
– sequence: 5
  givenname: Adam M.
  surname: Brickman
  fullname: Brickman, Adam M.
  organization: Columbia University
– sequence: 6
  givenname: Guojun
  surname: Bu
  fullname: Bu, Guojun
  organization: Mayo Clinic
– sequence: 7
  givenname: Jessica
  surname: Dennison
  fullname: Dennison, Jessica
  organization: University of Miami Miller School of Medicine
– sequence: 8
  givenname: Mary D.
  surname: Gearon
  fullname: Gearon, Mary D.
  organization: University of Kentucky
– sequence: 9
  givenname: Alison M.
  surname: Goate
  fullname: Goate, Alison M.
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 10
  givenname: Christian
  surname: Haass
  fullname: Haass, Christian
  organization: Germany 3 Munich Cluster for Systems Neurology (SyNergy)
– sequence: 11
  givenname: Michael T.
  surname: Heneka
  fullname: Heneka, Michael T.
  organization: Luxembourg Centre for Systems Biomedicine (LCSB) University of Luxembourg
– sequence: 12
  givenname: William T.
  surname: Hu
  fullname: Hu, William T.
  organization: Health Care Policy, and Aging Research
– sequence: 13
  givenname: Lenique K. L.
  surname: Huggins
  fullname: Huggins, Lenique K. L.
  organization: Yale School of Medicine
– sequence: 14
  givenname: Nahdia S.
  surname: Jones
  fullname: Jones, Nahdia S.
  organization: Georgetown University
– sequence: 15
  givenname: Radosveta
  surname: Koldamova
  fullname: Koldamova, Radosveta
  organization: School of Public Health University of Pittsburgh
– sequence: 16
  givenname: Cynthia A.
  surname: Lemere
  fullname: Lemere, Cynthia A.
  organization: Harvard Medical School
– sequence: 17
  givenname: Shane A.
  surname: Liddelow
  fullname: Liddelow, Shane A.
  organization: NYU Grossman School of Medicine
– sequence: 18
  givenname: Edoardo
  surname: Marcora
  fullname: Marcora, Edoardo
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 19
  givenname: Samuel E.
  surname: Marsh
  fullname: Marsh, Samuel E.
  organization: Broad Institute of MIT and Harvard
– sequence: 20
  givenname: Henrietta M.
  surname: Nielsen
  fullname: Nielsen, Henrietta M.
  organization: Stockholm University
– sequence: 21
  givenname: Kellen K.
  surname: Petersen
  fullname: Petersen, Kellen K.
  organization: Albert Einstein College of Medicine
– sequence: 22
  givenname: Melissa
  surname: Petersen
  fullname: Petersen, Melissa
  organization: University of North Texas Health Science Center
– sequence: 23
  givenname: Stefanie D.
  surname: Piña‐Escudero
  fullname: Piña‐Escudero, Stefanie D.
  organization: University of California
– sequence: 24
  givenname: Wei Qiao
  surname: Qiu
  fullname: Qiu, Wei Qiao
  organization: Boston University School of Medicine
– sequence: 25
  givenname: Yakeel T.
  surname: Quiroz
  fullname: Quiroz, Yakeel T.
  organization: Harvard Medical School
– sequence: 26
  givenname: Eric
  surname: Reiman
  fullname: Reiman, Eric
  organization: Banner Research
– sequence: 27
  givenname: Claire
  orcidid: 0000-0002-3846-2986
  surname: Sexton
  fullname: Sexton, Claire
  organization: Alzheimer's Association
– sequence: 28
  givenname: Malú Gámez
  surname: Tansey
  fullname: Tansey, Malú Gámez
  organization: University of Florida
– sequence: 29
  givenname: Julia
  surname: TCW
  fullname: TCW, Julia
  organization: Boston University School of Medicine
– sequence: 30
  givenname: Charlotte E.
  surname: Teunissen
  fullname: Teunissen, Charlotte E.
  organization: Vrije Universiteit Amsterdam
– sequence: 31
  givenname: Betty M.
  surname: Tijms
  fullname: Tijms, Betty M.
  organization: Neurodegeneration
– sequence: 32
  givenname: Rik
  surname: Kant
  fullname: Kant, Rik
  organization: Amsterdam University Medical Center
– sequence: 33
  givenname: Rebecca
  surname: Wallings
  fullname: Wallings, Rebecca
  organization: University of Florida
– sequence: 34
  givenname: Stacie C.
  surname: Weninger
  fullname: Weninger, Stacie C.
  organization: FBRI
– sequence: 35
  givenname: Whitney
  surname: Wharton
  fullname: Wharton, Whitney
  organization: EmoryUniversity
– sequence: 36
  givenname: Donna M.
  surname: Wilcock
  fullname: Wilcock, Donna M.
  organization: University of Kentucky
– sequence: 37
  givenname: Tyler James
  surname: Wishard
  fullname: Wishard, Tyler James
  organization: Los Angeles
– sequence: 38
  givenname: Susan L
  surname: Worley
  fullname: Worley, Susan L
  organization: Independent science writer
– sequence: 39
  givenname: Henrik
  surname: Zetterberg
  fullname: Zetterberg, Henrik
  organization: Clear Water Bay
– sequence: 40
  givenname: Maria C.
  surname: Carrillo
  fullname: Carrillo, Maria C.
  organization: Alzheimer's Association
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36975090$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-219590$$DView record from Swedish Publication Index
https://gup.ub.gu.se/publication/327516$$DView record from Swedish Publication Index
BookMark eNp90U1LwzAcBvAgE-emB7-A9CQKdstL0zbeypwvMJiIevASsjTtIn0zaRnz09vZuYMwDyEh_P5PIM8A9IqyUACcIThCEOKxyL5GiEAMD8AxohS7FAestzv7sA8G1n5A6MEQ0SPQJz4LKGTwGFxET_OpI4rY0XneFLpe3zjPyiph5NJZ6nSZtau2J-AwEZlVp9t9CF7vpi-TB3c2v3-cRDNXeoRClyYEe2H7TEwFDhTGKCEkECxkJGYqpoQxlZAgprGMqQwFxAKJgBEBF8IPZEiGwO1y7UpVzYJXRufCrHkpNE-birdXacOt4gQHFPmtv97rb_VbxEuTcttwjBhlsOWXHa9M-dkoW_NcW6myTBSqbCzHIaaIeqG_ST7f0maRq3iX_Pt1LbjqgDSltUYlO4Ig39TC21r4Ty2tHf-xUtei1mVRG6Gz_yZWOlPr_dE8mr13E9-UAJt-
CitedBy_id crossref_primary_10_1002_2211_5463_13704
crossref_primary_10_1002_alz_14291
crossref_primary_10_1016_j_imbio_2025_152895
crossref_primary_10_1111_pcn_13704
crossref_primary_10_1159_000541542
crossref_primary_10_3390_ijms241310440
crossref_primary_10_1002_wnan_1946
crossref_primary_10_3390_ijms251910432
crossref_primary_10_1016_j_arr_2024_102471
crossref_primary_10_3390_ijms241713395
Cites_doi 10.1038/s41591‐019‐0695‐9
10.1186/s13024‐015‐0048‐1
10.1073/pnas.0900345106
10.1212/NXG.0000000000000571
10.3233/JAD‐160163
10.1038/s41593‐021‐00905‐6
10.1038/s41591‐019‐0611‐3
10.1186/s13195‐019‐0546‐4
10.1126/science.aal3222
10.1194/jlr.R800069‐JLR200
10.2217/17460875.3.5.505
10.1371/journal.pone.0219668
10.1016/j.nbd.2022.105630
10.1007/s00109‐016‐1427‐y
10.1038/s41593‐020‐0602‐1
10.1016/j.biopsych.2017.05.014
10.1016/j.exger.2014.02.004
10.3390/nu7095341
10.1073/pnas.1525466113
10.1038/s41577‐018‐0051‐1
10.3389/fimmu.2020.00754
10.15252/emmm.201911227
10.1016/j.neuron.2017.04.043
10.1038/nn.3599
10.1177/0891988705281868
10.1038/s41593‐022‐01022‐8
10.1016/j.neurobiolaging.2012.09.012
10.1016/j.neuron.2017.09.003
10.1002/alz.051948
10.1016/j.jalz.2016.07.004
10.1016/j.neuron.2020.09.029
10.1038/s41467‐021‐22479‐4
10.1038/s41467‐021‐23762‐0
10.1186/s13195‐016‐0231‐9
10.1038/s41593‐018‐0296‐9
10.1016/j.neuron.2011.07.022
10.1038/s41586‐019‐0924‐x
10.1001/jamaneurol.2018.0821
10.1523/JNEUROSCI.3266‐12.2012
10.1523/JNEUROSCI.1871‐19.2019
10.1093/brain/awy188
10.1038/s41593‐019‐0560‐7
10.1126/science.abf9277
10.1016/0197‐4580(95)00021‐6
10.1038/s41467‐021‐24220‐7
10.1038/s41586‐019‐1195‐2
10.1016/j.neuron.2019.12.007
10.1016/S1474‐4422(15)70016‐5
10.1016/j.chom.2009.06.007
10.1016/j.brainresrev.2006.11.002
10.1186/s13024‐020‐00394‐4
10.1016/j.bbi.2021.12.008
10.1186/s12974‐020‐01915‐0
10.1016/j.cell.2017.05.018
10.1186/s40478‐021‐01263‐x
10.3892/etm.2021.9778
10.3389/fneur.2018.00625
10.1126/science.aay0793
10.1111/jgs.13627
10.1371/journal.pmed.1002270
10.2147/CLEP.S37929
10.3233/JAD‐150778
10.1001/jamapsychiatry.2014.1060
10.2174/1567205013666160930110551
10.1016/j.neuron.2020.10.008
10.1002/gps.4871
10.1523/JNEUROSCI.2262‐17.2018
10.1126/science.8346443
10.1016/j.neuron.2017.03.042
10.1017/s0317167100013949
10.1007/s00401‐020‐02193‐z
10.1038/s41467‐019‐14279‐8
10.1097/WAD.0000000000000462
10.1001/jamaneurol.2015.1721
10.1038/s41586‐021‐03960‐y
10.1124/pr.112.005850
10.1212/WNL.0000000000010629
10.1007/s12035‐014‐8657‐1
10.1126/science.abf7844
10.1016/j.neuron.2020.05.014
10.1016/j.jalz.2018.02.018
10.3233/JAD‐170767
10.1016/S1474‐4422(16)00067‐3
10.1084/jem.20200785
10.1016/j.immuni.2018.11.004
10.1212/wnl.43.8.1467
10.1038/s41582‐018‐0032‐9
10.3390/genes10030222
10.1186/s13195‐022‐01058‐9
10.1073/pnas.1525528113
10.3389/fimmu.2018.00586
10.1016/j.jns.2013.05.028
10.1038/s41593‐020‐0650‐6
10.1001/jama.2015.4668
10.3233/ADR‐200203
10.3389/fncel.2019.00063
10.1016/j.neurobiolaging.2012.03.002
10.3233/JAD‐210065
10.1016/j.nbd.2020.104755
10.1212/WNL.0000000000012512
10.1007/s00401‐014‐1375‐y
10.1186/s13195‐020‐00628‐z
10.1038/nn.4338
10.1371/journal.pmed.1002254
10.1016/j.neuron.2022.03.008
10.1038/nature21029
10.1002/alz.12205
10.1016/j.jalz.2015.12.007
10.1038/s41593‐022‐01061‐1
10.1002/iub.1314
10.1038/ncomms7176
10.15252/embj.201899430
10.1186/s13195‐017‐0313‐3
10.1093/brain/awaa325
10.1212/wnl.56.1.49
10.2147/jir.s4397
10.1016/j.nicl.2013.12.012
10.1073/pnas.90.5.1977
10.1093/jnen/nlab085
10.1016/j.jalz.2019.03.007
ContentType Journal Article
Copyright 2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Copyright_xml – notice: 2023 The Authors. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
– notice: 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ABAVF
ADTPV
AOWAS
D8T
DG7
ZZAVC
F1U
DOI 10.1002/alz.13020
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
SWEPUB Stockholms universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Stockholms universitet
SwePub Articles full text
SWEPUB Göteborgs universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1552-5279
EndPage 2696
ExternalDocumentID oai_gup_ub_gu_se_327516
oai_DiVA_org_su_219590
36975090
10_1002_alz_13020
ALZ13020
Genre reviewArticle
Research Support, U.S. Gov't, Non-P.H.S
Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: R01 AG054005
– fundername: NIA NIH HHS
  grantid: T32 AG000222
– fundername: NIA NIH HHS
  grantid: R01 AG077636
– fundername: NIA NIH HHS
  grantid: R01 AG076018
– fundername: NIAAA NIH HHS
  grantid: R01 AA016829
– fundername: NIA NIH HHS
  grantid: P30 AG059304
– fundername: NIA NIH HHS
  grantid: R01 AG067581
– fundername: NINDS NIH HHS
  grantid: UF1 NS125488
– fundername: NIA NIH HHS
  grantid: P01 AG078116
– fundername: NIA NIH HHS
  grantid: R01 AG066198
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1OC
1~.
1~5
24P
33P
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X7
8FI
8FJ
8P~
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAXLA
AAXUO
AAYCA
ABBQC
ABCQJ
ABCUV
ABIVO
ABJNI
ABMAC
ABMZM
ABUWG
ABWVN
ACCFJ
ACCMX
ACCZN
ACGFS
ACGOF
ACPOU
ACRPL
ACXQS
ADBBV
ADBTR
ADEZE
ADHUB
ADKYN
ADMUD
ADNMO
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AEVXI
AFKRA
AFTJW
AFWVQ
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
AZQEC
BENPR
BFHJK
BLXMC
C45
CCPQU
DCZOG
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYUFA
G-Q
GBLVA
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
K9-
LATKE
LEEKS
M0R
M41
MO0
MOBAO
N9A
NAPCQ
O-L
O9-
OAUVE
OVD
OVEED
OZT
P-8
P-9
P2P
PC.
PGMZT
PIMPY
PSYQQ
Q38
QTD
RIG
ROL
RPM
RPZ
SDF
SDG
SEL
SES
SSZ
SUPJJ
T5K
TEORI
UKHRP
~G-
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AGHNM
AIGII
AKBMS
AKYEP
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EFLBG
EIF
NPM
PJZUB
PPXIY
PUEGO
~HD
7X8
ABAVF
ADTPV
AOWAS
D8T
DG7
ZZAVC
F1U
ID FETCH-LOGICAL-c4350-5f3248040d5a27e221f337a9893d9ed5399ef37d5dcd5c8a02a1a793a0ba67c83
IEDL.DBID 24P
ISSN 1552-5260
1552-5279
IngestDate Wed Sep 10 03:17:37 EDT 2025
Wed Sep 10 00:31:03 EDT 2025
Fri Jul 11 03:47:04 EDT 2025
Wed Sep 24 03:02:35 EDT 2025
Tue Jul 01 01:52:15 EDT 2025
Thu Apr 24 22:54:43 EDT 2025
Wed Jan 22 16:20:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords biomarkers
neurodegeneration
tau
TREM2
amyloid beta
neuroglia
inflammation
neuroinflammation
dementia
APOE
astrocytes
Alzheimer's disease
microglia
Language English
License Attribution-NonCommercial-NoDerivs
2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4350-5f3248040d5a27e221f337a9893d9ed5399ef37d5dcd5c8a02a1a793a0ba67c83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-3846-2986
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.13020
PMID 36975090
PQID 2825154866
PQPubID 23479
PageCount 20
ParticipantIDs swepub_primary_oai_gup_ub_gu_se_327516
swepub_primary_oai_DiVA_org_su_219590
proquest_miscellaneous_2825154866
pubmed_primary_36975090
crossref_primary_10_1002_alz_13020
crossref_citationtrail_10_1002_alz_13020
wiley_primary_10_1002_alz_13020_ALZ13020
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2023
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: June 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Alzheimer's & dementia
PublicationTitleAlternate Alzheimers Dement
PublicationYear 2023
References 2019; 10
2015; 72
2019; 13
2019; 12
2019; 15
2019; 14
2019; 566
2020; 17
2022; 25
2020; 15
2020; 12
2020; 11
2018; 9
2022; 165
2019; 22
2020; 95
2011; 71
2019; 25
2020; 217
2014; 17
2001; 56
2018; 33
2017; 169
2018; 38
2021; 81
2021; 80
2022; 110
2016; 19
2020; 140
2020; 40
2020; 143
1993; 43
2019; 38
2016; 94
2012; 39
2015; 129
2016; 15
2012; 32
2016; 12
2022; 100
2018; 18
2015; 63
2020; 26
2022; 14
2013; 333
2021; 373
2020; 23
2017; 541
2019; 570
2005; 18
2018; 14
2009; 106
2021; 24
2021; 21
2019; 50
2019; 366
2018; 83
2008; 3
2008; 1
2017; 356
2017; 9
2014; 66
2021; 35
2020; 4
2014; 4
2009; 50
2021; 599
2020; 137
2016; 113
2014; 50
2018; 75
2014; 6
2012; 64
2014; 53
2021; 9
2021; 109
2018; 141
2021; 7
2015; 14
2015; 6
1995; 16
2015; 10
2016; 53
2020; 105
1993; 261
2020; 107
2016; 50
1993; 90
2018; 62
2007; 53
2015; 7
2020; 108
2017; 94
2017; 96
2021; 12
2017; 14
2015; 313
2021
2013; 34
2021; 17
2017; 13
2009; 6
2014; 71
e_1_2_12_6_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_111_1
e_1_2_12_115_1
e_1_2_12_108_1
e_1_2_12_20_1
e_1_2_12_66_1
e_1_2_12_43_1
e_1_2_12_85_1
e_1_2_12_24_1
e_1_2_12_47_1
e_1_2_12_89_1
e_1_2_12_62_1
e_1_2_12_81_1
e_1_2_12_100_1
e_1_2_12_123_1
e_1_2_12_28_1
e_1_2_12_104_1
e_1_2_12_31_1
e_1_2_12_77_1
e_1_2_12_54_1
e_1_2_12_96_1
e_1_2_12_35_1
e_1_2_12_58_1
e_1_2_12_12_1
e_1_2_12_73_1
e_1_2_12_50_1
e_1_2_12_92_1
e_1_2_12_3_1
e_1_2_12_18_1
e_1_2_12_110_1
e_1_2_12_114_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_63_1
e_1_2_12_86_1
e_1_2_12_107_1
e_1_2_12_25_1
e_1_2_12_48_1
e_1_2_12_67_1
e_1_2_12_40_1
e_1_2_12_82_1
e_1_2_12_122_1
e_1_2_12_29_1
e_1_2_12_103_1
e_1_2_12_119_1
e_1_2_12_32_1
e_1_2_12_55_1
e_1_2_12_74_1
e_1_2_12_97_1
e_1_2_12_36_1
e_1_2_12_59_1
e_1_2_12_78_1
e_1_2_12_13_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_70_1
e_1_2_12_93_1
e_1_2_12_4_1
e_1_2_12_19_1
e_1_2_12_38_1
e_1_2_12_113_1
e_1_2_12_41_1
e_1_2_12_87_1
e_1_2_12_106_1
e_1_2_12_22_1
e_1_2_12_64_1
e_1_2_12_45_1
e_1_2_12_26_1
e_1_2_12_68_1
e_1_2_12_83_1
e_1_2_12_60_1
e_1_2_12_49_1
e_1_2_12_121_1
e_1_2_12_102_1
e_1_2_12_52_1
e_1_2_12_98_1
e_1_2_12_118_1
e_1_2_12_33_1
e_1_2_12_75_1
e_1_2_12_56_1
e_1_2_12_37_1
e_1_2_12_79_1
e_1_2_12_14_1
e_1_2_12_90_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_94_1
e_1_2_12_71_1
e_1_2_12_5_1
e_1_2_12_16_1
e_1_2_12_112_1
e_1_2_12_39_1
e_1_2_12_116_1
e_1_2_12_42_1
e_1_2_12_65_1
e_1_2_12_88_1
e_1_2_12_109_1
e_1_2_12_23_1
e_1_2_12_46_1
e_1_2_12_69_1
e_1_2_12_80_1
e_1_2_12_61_1
e_1_2_12_84_1
e_1_2_12_27_1
e_1_2_12_101_1
e_1_2_12_120_1
e_1_2_12_105_1
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_76_1
e_1_2_12_99_1
e_1_2_12_117_1
e_1_2_12_34_1
e_1_2_12_57_1
e_1_2_12_15_1
e_1_2_12_91_1
e_1_2_12_11_1
e_1_2_12_72_1
e_1_2_12_95_1
e_1_2_12_9_1
References_xml – volume: 90
  start-page: 1977
  year: 1993
  end-page: 1981
  article-title: Apolipoprotein E: high‐avidity binding to beta‐amyloid and increased frequency of type 4 allele in late‐onset familial Alzheimer disease
  publication-title: Proc Natl Acad Sci USA
– volume: 143
  start-page: 3776
  year: 2020
  end-page: 3792
  article-title: Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics
  publication-title: Brain J Neurol
– volume: 23
  start-page: 167
  year: 2020
  end-page: 171
  article-title: Microglial microRNAs mediate sex‐specific responses to tau pathology
  publication-title: Nat Neurosci
– volume: 18
  start-page: 759
  year: 2018
  end-page: 772
  article-title: Interplay between innate immunity and Alzheimer disease: aPOE and TREM2 in the spotlight
  publication-title: Nat Rev Immunol
– volume: 19
  start-page: 987
  year: 2016
  end-page: 991
  article-title: A polarizing question: do M1 and M2 microglia exist?
  publication-title: Nat Neurosci
– volume: 599
  start-page: 102
  year: 2021
  end-page: 107
  article-title: Neurotoxic reactive astrocytes induce cell death via saturated lipids
  publication-title: Nature
– volume: 570
  start-page: 332
  year: 2019
  end-page: 337
  article-title: Single‐cell transcriptomic analysis of Alzheimer's disease
  publication-title: Nature
– volume: 15
  start-page: 451
  year: 2016
  end-page: 452
  article-title: Sex differences in Alzheimer's disease and other dementias
  publication-title: Lancet Neurol
– volume: 14
  start-page: 457
  year: 2018
  end-page: 469
  article-title: Sex differences in Alzheimer disease ‐ the gateway to precision medicine
  publication-title: Nat Rev Neurol
– volume: 50
  start-page: 534
  year: 2014
  end-page: 544
  article-title: Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview
  publication-title: Mol Neurobiol
– volume: 50
  start-page: S183
  year: 2009
  end-page: S188
  article-title: Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
  publication-title: J Lipid Res
– volume: 81
  start-page: 339
  year: 2021
  end-page: 354
  article-title: Plasma apolipoprotein E3 and glucose levels are associated in APOE ɛ3/ɛ4 carriers
  publication-title: J Alzheimers Dis JAD
– volume: 165
  year: 2022
  article-title: Soluble TREM2: innocent bystander or active player in neurological diseases?
  publication-title: Neurobiol Dis
– volume: 12
  start-page: 216
  year: 2016
  end-page: 224
  article-title: Inequalities in dementia incidence between six racial and ethnic groups over 14 years
  publication-title: Alzheimers Dement J Alzheimers Assoc
– volume: 50
  start-page: 71
  year: 2016
  end-page: 76
  article-title: A meta‐analysis of Alzheimer's disease incidence and prevalence comparing African‐Americans and Caucasians
  publication-title: J Alzheimers Dis JAD
– volume: 6
  start-page: 10
  year: 2009
  end-page: 21
  article-title: Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system
  publication-title: Cell Host Microbe
– volume: 72
  start-page: 1124
  year: 2015
  end-page: 1131
  article-title: Characterizing apolipoprotein E ε4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal β‐amyloid peptide plaques
  publication-title: JAMA Neurol
– volume: 39
  start-page: 436
  year: 2012
  end-page: 445
  article-title: Early‐onset familial Alzheimer's disease (EOFAD)
  publication-title: Can J Neurol Sci J Can Sci Neurol
– volume: 100
  start-page: 243
  year: 2022
  end-page: 253
  article-title: Associations of circulating C‐reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan
  publication-title: Brain Behav Immun
– volume: 34
  start-page: 1051
  year: 2013
  end-page: 1059
  article-title: Neuroinflammatory phenotype in early Alzheimer's disease
  publication-title: Neurobiol Aging
– volume: 62
  start-page: 833
  year: 2018
  end-page: 840
  article-title: Longitudinal changes in serum glucose levels are associated with metabolic changes in Alzheimer's disease related brain regions
  publication-title: J Alzheimers Dis JAD
– volume: 12
  start-page: 65
  year: 2020
  article-title: APOE ε4 genotype‐dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease
  publication-title: Alzheimers Res Ther
– volume: 129
  start-page: 167
  year: 2015
  end-page: 182
  article-title: Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease
  publication-title: Acta Neuropathol (Berl)
– volume: 16
  start-page: 271
  year: 1995
  end-page: 278
  article-title: Staging of Alzheimer's disease‐related neurofibrillary changes
  publication-title: Neurobiol Aging
– volume: 9
  start-page: 586
  year: 2018
  article-title: Age and age‐related diseases: role of inflammation triggers and cytokines
  publication-title: Front Immunol
– volume: 94
  start-page: 759
  year: 2017
  end-page: 773
  article-title: Diverse requirements for microglial survival, specification, and function revealed by defined‐medium cultures
  publication-title: Neuron
– volume: 23
  start-page: 927
  year: 2020
  end-page: 938
  article-title: Alzheimer's‐associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
  publication-title: Nat Neurosci
– volume: 53
  start-page: 344
  year: 2007
  end-page: 354
  article-title: The origin and cell lineage of microglia: new concepts
  publication-title: Brain Res Rev
– volume: 14
  year: 2019
  article-title: The impact of APOE genotype on survival: results of 38,537 participants from six population‐based cohorts (E2‐CHARGE)
  publication-title: PLoS ONE
– volume: 94
  start-page: 739
  year: 2016
  end-page: 746
  article-title: Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
  publication-title: J Mol Med Berl Ger
– volume: 4
  start-page: 281
  year: 2020
  end-page: 286
  article-title: Influence of APOE genotype on mortality and cognitive impairment
  publication-title: J Alzheimers Dis Rep
– volume: 11
  start-page: 754
  year: 2020
  article-title: The important interface between apolipoprotein E and neuroinflammation in Alzheimer's disease
  publication-title: Front Immunol
– volume: 217
  year: 2020
  article-title: Anti‐human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model
  publication-title: J Exp Med
– volume: 373
  year: 2021
  article-title: Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders
  publication-title: Science
– volume: 313
  start-page: 1924
  year: 2015
  end-page: 1938
  article-title: Prevalence of cerebral amyloid pathology in persons without dementia: a meta‐analysis
  publication-title: JAMA
– volume: 13
  start-page: 63
  year: 2019
  article-title: Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration
  publication-title: Front Cell Neurosci
– volume: 373
  year: 2021
  article-title: Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma
  publication-title: Science
– volume: 35
  start-page: 306
  year: 2021
  end-page: 314
  article-title: A comparison of methods for predicting future cognitive status: mixture modeling, latent class analysis, and competitors
  publication-title: Alzheimer Dis Assoc Disord
– volume: 113
  start-page: E1316
  year: 2016
  end-page: E1325
  article-title: The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function
  publication-title: Proc Natl Acad Sci U S A
– volume: 25
  start-page: 306
  year: 2022
  end-page: 316
  article-title: Dissection of artifactual and confounding glial signatures by single‐cell sequencing of mouse and human brain
  publication-title: Nat Neurosci
– volume: 113
  start-page: E1738
  year: 2016
  end-page: E1746
  article-title: New tools for studying microglia in the mouse and human CNS
  publication-title: Proc Natl Acad Sci USA
– volume: 12
  start-page: 2185
  year: 2021
  article-title: Therapeutic B‐cell depletion reverses progression of Alzheimer's disease
  publication-title: Nat Commun
– volume: 12
  year: 2020
  article-title: Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
  publication-title: EMBO Mol Med
– volume: 40
  start-page: 1956
  year: 2020
  end-page: 1974
  article-title: Trem2 deletion reduces late‐stage amyloid plaque accumulation, elevates the Aβ42:aβ40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's Mouse Model
  publication-title: J Neurosci Off J Soc Neurosci
– volume: 3
  start-page: 505
  year: 2008
  end-page: 530
  article-title: Apolipoprotein E and cholesterol in aging and disease in the brain
  publication-title: Future Lipidol
– volume: 137
  year: 2020
  article-title: ApoE and cerebral insulin: trafficking, receptors, and resistance
  publication-title: Neurobiol Dis
– volume: 94
  start-page: 278
  year: 2017
  end-page: 293
  article-title: iPSC‐derived human microglia‐like cells to study neurological diseases
  publication-title: Neuron
– volume: 22
  start-page: 191
  year: 2019
  end-page: 204
  article-title: Loss of TREM2 function increases amyloid seeding but reduces plaque‐associated ApoE
  publication-title: Nat Neurosci
– year: 2021
  article-title: Impact of C‐reactive protein on cognition and Alzheimer disease biomarkers in homozygous apolipoprotein E ɛ4 carriers
  publication-title: Neurology
– volume: 7
  year: 2021
  article-title: African Americans have differences in CSF soluble TREM2 and associated genetic variants
  publication-title: Neurol Genet
– volume: 7
  start-page: 7332
  year: 2015
  end-page: 7357
  article-title: Shared neuropathological characteristics of obesity, Type 2 diabetes and Alzheimer's disease: impacts on cognitive decline
  publication-title: Nutrients
– volume: 25
  start-page: 1680
  year: 2019
  end-page: 1983
  article-title: Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report
  publication-title: Nat Med
– volume: 80
  start-page: 922
  year: 2021
  end-page: 932
  article-title: Inflammatory pathways are impaired in Alzheimer disease and differentially associated With apolipoprotein E status
  publication-title: J Neuropathol Exp Neurol
– volume: 71
  start-page: 799
  year: 2011
  end-page: 811
  article-title: Development of a method for the purification and culture of rodent astrocytes
  publication-title: Neuron
– volume: 261
  start-page: 921
  year: 1993
  end-page: 923
  article-title: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
  publication-title: Science
– volume: 108
  start-page: 801
  year: 2020
  end-page: 821
  article-title: Emerging microglia biology defines novel therapeutic approaches for Alzheimer's disease
  publication-title: Neuron
– volume: 169
  start-page: 1276
  year: 2017
  end-page: 1290
  article-title: A unique microglia type associated with restricting development of Alzheimer's disease
  publication-title: Cell
– volume: 75
  start-page: 989
  year: 2018
  end-page: 998
  article-title: Sex‐specific association of apolipoprotein E with cerebrospinal fluid levels of Tau
  publication-title: JAMA Neurol
– volume: 6
  start-page: 37
  year: 2014
  end-page: 48
  article-title: Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences
  publication-title: Clin Epidemiol
– volume: 105
  start-page: 837
  year: 2020
  end-page: 854
  article-title: TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
  publication-title: Neuron
– volume: 83
  start-page: 300
  year: 2018
  end-page: 310
  article-title: Untangling genetic risk for Alzheimer's disease
  publication-title: Biol Psychiatry
– volume: 18
  start-page: 213
  year: 2005
  end-page: 217
  article-title: Cognitive decline and literacy among ethnically diverse elders
  publication-title: J Geriatr Psychiatry Neurol
– volume: 64
  start-page: 1004
  year: 2012
  end-page: 1026
  article-title: Tumor necrosis factor‐induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales
  publication-title: Pharmacol Rev
– volume: 21
  start-page: 347
  year: 2021
  article-title: The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: a systematic review and meta‐analysis
  publication-title: Exp Ther Med
– volume: 56
  start-page: 49
  year: 2001
  end-page: 56
  article-title: Incidence of AD in African‐Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
  publication-title: Neurology
– volume: 11
  start-page: 667
  year: 2020
  article-title: Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000‐person neuropathological study
  publication-title: Nat Commun
– volume: 1
  start-page: 29
  year: 2008
  end-page: 39
  article-title: Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease
  publication-title: J Inflamm Res
– volume: 107
  start-page: 436
  year: 2020
  end-page: 453
  article-title: CD49f is a novel marker of functional and reactive human iPSC‐derived astrocytes
  publication-title: Neuron
– volume: 33
  start-page: 688
  year: 2018
  end-page: 694
  article-title: TNF alpha inhibitors in Alzheimer's disease: a systematic review
  publication-title: Int J Geriatr Psychiatry
– volume: 6
  start-page: 6176
  year: 2015
  article-title: Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
  publication-title: Nat Commun
– volume: 106
  start-page: 6820
  year: 2009
  end-page: 6825
  article-title: Fibrillar amyloid‐beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
  publication-title: Proc Natl Acad Sci U S A
– volume: 140
  start-page: 513
  year: 2020
  end-page: 534
  article-title: TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
  publication-title: Acta Neuropathol (Berl)
– volume: 17
  start-page: 238
  year: 2020
  article-title: Therapeutic Trem2 activation ameliorates amyloid‐beta deposition and improves cognition in the 5XFAD model of amyloid deposition
  publication-title: J Neuroinflammation
– volume: 356
  year: 2017
  article-title: An environment‐dependent transcriptional network specifies human microglia identity
  publication-title: Science
– volume: 25
  start-page: 588
  year: 2022
  end-page: 595
  article-title: Single‐cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease
  publication-title: Nat Neurosci
– volume: 14
  year: 2017
  article-title: APP, PSEN1, and PSEN2 mutations in early‐onset Alzheimer disease: a genetic screening study of familial and sporadic cases
  publication-title: PLoS Med
– volume: 38
  year: 2019
  article-title: Beclin1‐driven autophagy modulates the inflammatory response of microglia via NLRP3
  publication-title: EMBO J
– volume: 10
  start-page: 52
  year: 2015
  article-title: Genetics ignite focus on microglial inflammation in Alzheimer's disease
  publication-title: Mol Neurodegener
– volume: 15
  start-page: 41
  year: 2020
  article-title: Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
  publication-title: Mol Neurodegener
– volume: 9
  start-page: 5
  year: 2017
  article-title: Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
  publication-title: Alzheimers Res Ther
– volume: 15
  start-page: 776
  year: 2019
  end-page: 787
  article-title: Inflammatory biomarkers in Alzheimer's disease plasma
  publication-title: Alzheimers Dement J Alzheimers Assoc
– volume: 4
  start-page: 461
  year: 2014
  end-page: 472
  article-title: ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
  publication-title: NeuroImage Clin
– volume: 108
  start-page: 801
  year: 2020
  end-page: 821
  article-title: Emerging microglia biology defines novel therapeutic approaches for Alzheimer's disease ‐ ScienceDirect 2020
  publication-title: Neuron
– volume: 63
  start-page: 1749
  year: 2015
  end-page: 1756
  article-title: Modulation of renin‐angiotensin system may slow conversion from mild cognitive umpairment to Alzheimer's disease
  publication-title: J Am Geriatr Soc
– volume: 366
  start-page: 1134
  year: 2019
  end-page: 1139
  article-title: Brain cell type‐specific enhancer‐promoter interactome maps and disease‐risk association
  publication-title: Science
– volume: 12
  start-page: 3416
  year: 2021
  article-title: Phospholipids of APOE lipoproteins activate microglia in an isoform‐specific manner in preclinical models of Alzheimer's disease
  publication-title: Nat Commun
– volume: 17
  start-page: 131
  year: 2014
  end-page: 143
  article-title: Identification of a unique TGF‐β‐dependent molecular and functional signature in microglia
  publication-title: Nat Neurosci
– volume: 12
  start-page: 4001
  year: 2021
  article-title: Higher CSF sTNFR1‐related proteins associate with better prognosis in very early Alzheimer's disease
  publication-title: Nat Commun
– volume: 95
  start-page: e2378
  year: 2020
  end-page: e2388
  article-title: Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype
  publication-title: Neurology
– volume: 14
  start-page: 535
  year: 2018
  end-page: 562
  article-title: NIA‐AA Research Framework: toward a biological definition of Alzheimer's disease
  publication-title: Alzheimers Dement J Alzheimers Assoc
– volume: 333
  start-page: 9
  year: 2013
  end-page: 12
  article-title: Association of plasma C‐reactive protein levels with the diagnosis of Alzheimer's disease
  publication-title: J Neurol Sci
– volume: 17
  start-page: 466
  year: 2021
  end-page: 474
  article-title: APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos‐investigation of neurocognitive aging (HCHS/SOL)
  publication-title: Alzheimers Dement
– volume: 96
  start-page: 115
  year: 2017
  end-page: 129
  article-title: Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes
  publication-title: Neuron
– volume: 141
  start-page: 2740
  year: 2018
  end-page: 2754
  article-title: Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
  publication-title: Brain
– volume: 50
  start-page: 253
  year: 2019
  end-page: 271
  article-title: Single‐cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell‐state changes
  publication-title: Immunity
– volume: 9
  start-page: 625
  year: 2018
  article-title: In vivo imaging of glial activation in Alzheimer's disease
  publication-title: Front Neurol
– volume: 566
  start-page: 388
  year: 2019
  end-page: 392
  article-title: Spatial and temporal heterogeneity of mouse and human microglia at single‐cell resolution
  publication-title: Nature
– volume: 24
  start-page: 1475
  year: 2021
  end-page: 1487
  article-title: Neuroinflammatory astrocyte subtypes in the mouse brain
  publication-title: Nat Neurosci
– volume: 14
  start-page: 115
  year: 2022
  article-title: Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease
  publication-title: Alzheimers Res Ther
– volume: 38
  start-page: 6665
  year: 2018
  end-page: 6681
  article-title: Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention
  publication-title: J Neurosci Off J Soc Neurosci
– volume: 71
  start-page: 1183
  year: 2014
  end-page: 1191
  article-title: Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease
  publication-title: JAMA Psychiatry
– volume: 9
  start-page: 168
  year: 2021
  article-title: TREM2 modulates differential deposition of modified and non‐modified Aβ species in extracellular plaques and intraneuronal deposits
  publication-title: Acta Neuropathol Commun
– volume: 14
  year: 2017
  article-title: APOE‐related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts
  publication-title: PLoS Med
– volume: 53
  start-page: 1553
  year: 2016
  end-page: 1562
  article-title: Interaction between midlife blood glucose and APOE genotype predicts later Alzheimer's disease pathology
  publication-title: J Alzheimers Dis JAD
– volume: 53
  start-page: 16
  year: 2014
  end-page: 23
  article-title: ApoE gene and exceptional longevity: insights from three independent cohorts
  publication-title: Exp Gerontol
– volume: 109
  start-page: 205
  year: 2021
  end-page: 221
  article-title: Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis
  publication-title: Neuron
– volume: 9
  start-page: 87
  year: 2017
  article-title: Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
  publication-title: Alzheimers Res Ther
– volume: 14
  start-page: 412
  year: 2017
  end-page: 425
  article-title: Targeting tumor necrosis factor alpha for Alzheimer's disease
  publication-title: Curr Alzheimer Res
– volume: 26
  start-page: 131
  year: 2020
  end-page: 142
  article-title: Human and mouse single‐nucleus transcriptomics reveal TREM2‐dependent and TREM2‐independent cellular responses in Alzheimer's disease
  publication-title: Nat Med
– volume: 10
  start-page: 222
  year: 2019
  article-title: The genetic variability of APOE in different human populations and its implications for longevity
  publication-title: Genes
– volume: 43
  start-page: 1467
  year: 1993
  end-page: 1472
  article-title: Association of apolipoprotein E allele epsilon 4 with late‐onset familial and sporadic Alzheimer's disease
  publication-title: Neurology
– volume: 32
  start-page: 18227
  year: 2012
  end-page: 18233
  article-title: Initiative F the ADN. Apolipoprotein E, not fibrillar β‐amyloid, reduces cerebral glucose metabolism in normal aging
  publication-title: J Neurosci
– volume: 541
  start-page: 481
  year: 2017
  end-page: 487
  article-title: Neurotoxic reactive astrocytes are induced by activated microglia
  publication-title: Nature
– volume: 34
  start-page: 22
  year: 2013
  end-page: 34
  article-title: Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents
  publication-title: Neurobiol Aging
– volume: 14
  start-page: 388
  year: 2015
  end-page: 405
  article-title: Neuroinflammation in Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 66
  start-page: 616
  year: 2014
  end-page: 623
  article-title: Apolipoprotein E isoforms and lipoprotein metabolism
  publication-title: IUBMB Life
– volume: 12
  start-page: 1
  year: 2019
  article-title: Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late‐onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetes
  publication-title: Alzheimers Res Ther
– volume: 110
  start-page: 1788
  year: 2022
  end-page: 1805
  article-title: Astrocytes and oligodendrocytes undergo subtype‐specific transcriptional changes in Alzheimer's disease
  publication-title: Neuron
– volume: 23
  start-page: 500
  year: 2020
  end-page: 509
  article-title: Astrocyte layers in the mammalian cerebral cortex revealed by a single‐cell in situ transcriptomic map
  publication-title: Nat Neurosci
– volume: 13
  start-page: 381
  year: 2017
  end-page: 387
  article-title: Alzheimer's disease‐associated TREM2 variants exhibit either decreased or increased ligand‐dependent activation
  publication-title: Alzheimers Dement J Alzheimers Assoc
– ident: e_1_2_12_66_1
  doi: 10.1038/s41591‐019‐0695‐9
– ident: e_1_2_12_103_1
  doi: 10.1186/s13024‐015‐0048‐1
– ident: e_1_2_12_117_1
  doi: 10.1073/pnas.0900345106
– ident: e_1_2_12_90_1
  doi: 10.1212/NXG.0000000000000571
– ident: e_1_2_12_27_1
  doi: 10.3233/JAD‐160163
– ident: e_1_2_12_71_1
  doi: 10.1038/s41593‐021‐00905‐6
– ident: e_1_2_12_114_1
  doi: 10.1038/s41591‐019‐0611‐3
– ident: e_1_2_12_123_1
  doi: 10.1186/s13195‐019‐0546‐4
– ident: e_1_2_12_69_1
  doi: 10.1126/science.aal3222
– ident: e_1_2_12_19_1
  doi: 10.1194/jlr.R800069‐JLR200
– ident: e_1_2_12_15_1
  doi: 10.2217/17460875.3.5.505
– ident: e_1_2_12_85_1
  doi: 10.1371/journal.pone.0219668
– ident: e_1_2_12_113_1
  doi: 10.1016/j.nbd.2022.105630
– ident: e_1_2_12_13_1
  doi: 10.1007/s00109‐016‐1427‐y
– ident: e_1_2_12_72_1
  doi: 10.1038/s41593‐020‐0602‐1
– ident: e_1_2_12_7_1
  doi: 10.1016/j.biopsych.2017.05.014
– ident: e_1_2_12_18_1
  doi: 10.1016/j.exger.2014.02.004
– ident: e_1_2_12_24_1
  doi: 10.3390/nu7095341
– ident: e_1_2_12_45_1
  doi: 10.1073/pnas.1525466113
– ident: e_1_2_12_11_1
  doi: 10.1038/s41577‐018‐0051‐1
– ident: e_1_2_12_42_1
  doi: 10.3389/fimmu.2020.00754
– ident: e_1_2_12_108_1
  doi: 10.15252/emmm.201911227
– ident: e_1_2_12_68_1
  doi: 10.1016/j.neuron.2017.04.043
– ident: e_1_2_12_55_1
  doi: 10.1038/nn.3599
– ident: e_1_2_12_100_1
  doi: 10.1177/0891988705281868
– ident: e_1_2_12_63_1
  doi: 10.1038/s41593‐022‐01022‐8
– ident: e_1_2_12_41_1
  doi: 10.1016/j.neurobiolaging.2012.09.012
– ident: e_1_2_12_21_1
  doi: 10.1016/j.neuron.2017.09.003
– ident: e_1_2_12_97_1
  doi: 10.1002/alz.051948
– ident: e_1_2_12_104_1
  doi: 10.1016/j.jalz.2016.07.004
– ident: e_1_2_12_59_1
  doi: 10.1016/j.neuron.2020.09.029
– ident: e_1_2_12_46_1
  doi: 10.1038/s41467‐021‐22479‐4
– ident: e_1_2_12_77_1
  doi: 10.1038/s41467‐021‐23762‐0
– ident: e_1_2_12_32_1
– ident: e_1_2_12_28_1
  doi: 10.1186/s13195‐016‐0231‐9
– ident: e_1_2_12_58_1
  doi: 10.1038/s41593‐018‐0296‐9
– ident: e_1_2_12_64_1
  doi: 10.1016/j.neuron.2011.07.022
– ident: e_1_2_12_65_1
  doi: 10.1038/s41586‐019‐0924‐x
– ident: e_1_2_12_94_1
  doi: 10.1001/jamaneurol.2018.0821
– ident: e_1_2_12_22_1
  doi: 10.1523/JNEUROSCI.3266‐12.2012
– ident: e_1_2_12_109_1
  doi: 10.1523/JNEUROSCI.1871‐19.2019
– ident: e_1_2_12_39_1
  doi: 10.1093/brain/awy188
– ident: e_1_2_12_93_1
  doi: 10.1038/s41593‐019‐0560‐7
– ident: e_1_2_12_48_1
  doi: 10.1126/science.abf9277
– ident: e_1_2_12_3_1
  doi: 10.1016/0197‐4580(95)00021‐6
– ident: e_1_2_12_84_1
  doi: 10.1038/s41467‐021‐24220‐7
– ident: e_1_2_12_75_1
  doi: 10.1038/s41586‐019‐1195‐2
– ident: e_1_2_12_57_1
  doi: 10.1016/j.neuron.2019.12.007
– ident: e_1_2_12_34_1
  doi: 10.1016/S1474‐4422(15)70016‐5
– ident: e_1_2_12_50_1
  doi: 10.1016/j.chom.2009.06.007
– ident: e_1_2_12_49_1
  doi: 10.1016/j.brainresrev.2006.11.002
– ident: e_1_2_12_78_1
  doi: 10.1186/s13024‐020‐00394‐4
– ident: e_1_2_12_31_1
  doi: 10.1016/j.bbi.2021.12.008
– ident: e_1_2_12_111_1
  doi: 10.1186/s12974‐020‐01915‐0
– ident: e_1_2_12_56_1
  doi: 10.1016/j.cell.2017.05.018
– ident: e_1_2_12_110_1
  doi: 10.1186/s40478‐021‐01263‐x
– ident: e_1_2_12_76_1
  doi: 10.3892/etm.2021.9778
– ident: e_1_2_12_38_1
  doi: 10.3389/fneur.2018.00625
– ident: e_1_2_12_61_1
  doi: 10.1126/science.aay0793
– ident: e_1_2_12_102_1
  doi: 10.1111/jgs.13627
– ident: e_1_2_12_5_1
  doi: 10.1371/journal.pmed.1002270
– ident: e_1_2_12_96_1
  doi: 10.2147/CLEP.S37929
– ident: e_1_2_12_101_1
  doi: 10.3233/JAD‐150778
– ident: e_1_2_12_81_1
  doi: 10.1001/jamapsychiatry.2014.1060
– ident: e_1_2_12_119_1
  doi: 10.2174/1567205013666160930110551
– ident: e_1_2_12_14_1
  doi: 10.1016/j.neuron.2020.10.008
– ident: e_1_2_12_120_1
  doi: 10.1002/gps.4871
– ident: e_1_2_12_107_1
  doi: 10.1016/j.neuron.2020.09.029
– ident: e_1_2_12_23_1
  doi: 10.1523/JNEUROSCI.2262‐17.2018
– ident: e_1_2_12_8_1
  doi: 10.1126/science.8346443
– ident: e_1_2_12_62_1
  doi: 10.1016/j.neuron.2017.03.042
– ident: e_1_2_12_6_1
  doi: 10.1017/s0317167100013949
– ident: e_1_2_12_112_1
  doi: 10.1007/s00401‐020‐02193‐z
– ident: e_1_2_12_115_1
  doi: 10.1038/s41467‐019‐14279‐8
– ident: e_1_2_12_86_1
  doi: 10.1097/WAD.0000000000000462
– ident: e_1_2_12_116_1
  doi: 10.1001/jamaneurol.2015.1721
– ident: e_1_2_12_44_1
  doi: 10.1038/s41586‐021‐03960‐y
– ident: e_1_2_12_122_1
  doi: 10.1124/pr.112.005850
– ident: e_1_2_12_95_1
  doi: 10.1212/WNL.0000000000010629
– ident: e_1_2_12_36_1
  doi: 10.1007/s12035‐014‐8657‐1
– ident: e_1_2_12_47_1
  doi: 10.1126/science.abf7844
– ident: e_1_2_12_54_1
  doi: 10.1016/j.neuron.2020.05.014
– ident: e_1_2_12_4_1
  doi: 10.1016/j.jalz.2018.02.018
– ident: e_1_2_12_26_1
  doi: 10.3233/JAD‐170767
– ident: e_1_2_12_92_1
  doi: 10.1016/S1474‐4422(16)00067‐3
– ident: e_1_2_12_106_1
  doi: 10.1084/jem.20200785
– ident: e_1_2_12_73_1
  doi: 10.1016/j.immuni.2018.11.004
– ident: e_1_2_12_10_1
  doi: 10.1212/wnl.43.8.1467
– ident: e_1_2_12_91_1
  doi: 10.1038/s41582‐018‐0032‐9
– ident: e_1_2_12_88_1
  doi: 10.3390/genes10030222
– ident: e_1_2_12_79_1
  doi: 10.1186/s13195‐022‐01058‐9
– ident: e_1_2_12_70_1
  doi: 10.1073/pnas.1525528113
– ident: e_1_2_12_43_1
  doi: 10.3389/fimmu.2018.00586
– ident: e_1_2_12_30_1
  doi: 10.1016/j.jns.2013.05.028
– ident: e_1_2_12_105_1
  doi: 10.1038/s41593‐020‐0650‐6
– ident: e_1_2_12_118_1
  doi: 10.1001/jama.2015.4668
– ident: e_1_2_12_87_1
  doi: 10.3233/ADR‐200203
– ident: e_1_2_12_35_1
  doi: 10.3389/fncel.2019.00063
– ident: e_1_2_12_25_1
  doi: 10.1016/j.neurobiolaging.2012.03.002
– ident: e_1_2_12_29_1
  doi: 10.3233/JAD‐210065
– ident: e_1_2_12_20_1
  doi: 10.1016/j.nbd.2020.104755
– ident: e_1_2_12_33_1
  doi: 10.1212/WNL.0000000000012512
– ident: e_1_2_12_2_1
  doi: 10.1007/s00401‐014‐1375‐y
– ident: e_1_2_12_40_1
  doi: 10.1186/s13195‐020‐00628‐z
– ident: e_1_2_12_60_1
  doi: 10.1038/nn.4338
– ident: e_1_2_12_17_1
  doi: 10.1371/journal.pmed.1002254
– ident: e_1_2_12_74_1
  doi: 10.1016/j.neuron.2022.03.008
– ident: e_1_2_12_53_1
  doi: 10.1038/nature21029
– ident: e_1_2_12_89_1
  doi: 10.1002/alz.12205
– ident: e_1_2_12_98_1
  doi: 10.1016/j.jalz.2015.12.007
– ident: e_1_2_12_67_1
  doi: 10.1038/s41593‐022‐01061‐1
– ident: e_1_2_12_16_1
  doi: 10.1002/iub.1314
– ident: e_1_2_12_51_1
  doi: 10.1038/ncomms7176
– ident: e_1_2_12_52_1
  doi: 10.15252/embj.201899430
– ident: e_1_2_12_80_1
  doi: 10.1186/s13195‐017‐0313‐3
– ident: e_1_2_12_83_1
  doi: 10.1093/brain/awaa325
– ident: e_1_2_12_99_1
  doi: 10.1212/wnl.56.1.49
– ident: e_1_2_12_121_1
  doi: 10.2147/jir.s4397
– ident: e_1_2_12_82_1
  doi: 10.1016/j.nicl.2013.12.012
– ident: e_1_2_12_9_1
  doi: 10.1073/pnas.90.5.1977
– ident: e_1_2_12_12_1
  doi: 10.1093/jnen/nlab085
– ident: e_1_2_12_37_1
  doi: 10.1016/j.jalz.2019.03.007
SSID ssj0040815
Score 2.4582667
SecondaryResourceType review_article
Snippet INTRODUCTION At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research...
At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on...
INTRODUCTION:  At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research...
INTRODUCTIONAt the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research...
SourceID swepub
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2677
SubjectTerms Alzheimer Disease - pathology
Alzheimer's disease
amyloid beta
APOE
Apolipoproteins E - genetics
astrocytes
biomarkers
dementia
Humans
Inflammation
microglia
Microglia - pathology
neurodegeneration
neuroglia
neuroinflammation
Neurosciences
Neurovetenskaper
tau
TREM2
Title APOE and immunity: Research highlights
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falz.13020
https://www.ncbi.nlm.nih.gov/pubmed/36975090
https://www.proquest.com/docview/2825154866
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-219590
https://gup.ub.gu.se/publication/327516
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA-iFy-i-DU_RhUduxTbtElaPQ23ISLqwY3hJaRJOgajG3Y96F_vS7pWhhO8hfalTV_ykt9L834PoSuNTc-SxI2ZiNwQYwk2Bz4PS6mIw9QXsbAHZJ_pwyB8HJHRBrqrYmFKfoh6w81Yhp2vjYGLJL_5IQ0V0y-TyhiDv74FoD4wwxuHr9U0HMJaRyxZKjHeFvUqWiEP39RVVxejXwizpg9dRa526envop0lZnQ6ZSfvoQ2d7aNW5_Wl54hMORMb4rH4vHWqY3SOISGeGrc7P0CDfu_t_sFdJj1wJSAXzyUpQJwImq-IwExj7KdBwEQMuELFWhkiWZ0GTBElFZGR8LDwBRiZ8BJBmYyCQ7SZzTJ9jJwkZZGS1KdM09CTMoZykCqfxqnnC081ULv6ei6XjOAmMcWUl1zGmIOiuFVUA13WovOSBmOd0EWlQg6D1Px5EJmeFTm3AbLgG1HaQEelbuvHBDQ2qAVqX5fKru8Y5uvuZNjhs48xzwuODREOyLXWyI2LOYdL44LnmgeYER9e1bad9neDeefp3RZO_i96irZNxvnytNgZ2lx8FPoccMkiadrx10RbL8Ner_sNXQLcyA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA9DD3oRxa_5WUWHl7I2bZJWvAw_mDqnB5XhJWRJOgajG9t60L_el3StDCd4C-1Lm77kJb-X5v0eQmcam54lXTdmInJDjCXYHPg8LKEiDhNfxMIekG3T5lv40CGdCroqYmFyfohyw81Yhp2vjYGbDen6D2uoGHyZXMYYHPblkILrYnidw5diHg5hsSOWLZUYd4t6Ba-Qh-tl1fnV6BfELPlD56GrXXvu1tHaDDQ6jbyXN1BFp5uo1nh5vnVEqpy-jfGYfl46xTk6x7AQD4zfPdlCb3e3r9dNd5b1wJUAXTyXJIBxImi-IgIzjbGfBAETMQALFWtlmGR1EjBFlFRERsLDwhdgZcLrCspkFGyjpXSY6l3kdBMWKUl9yjQNPSljKAeJ8mmceL7wVBVdFF_P5YwS3GSmGPCczBhzUBS3iqqi01J0lPNgLBI6KVTIYZSaXw8i1cNswm2ELDhHlFbRTq7b8jEBjQ1sgdrnubLLO4b6-qb_3uDDcY9PMo4NEw7I1RbI9bIRh0u9jE80DzAjPrzqwnba3w3mjdaHLez9X_QYrTRfn1q8dd9-3EerJv18fnTsAC1Nx5k-BJAy7R7ZsfgNT6bemA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFA6iIL6I4m1eq6j4UtamTdLq03COeUH3oDJ8CVkuQxjdcOuD_npP0rUynOBbaE_a9OSc5Dtp8h2ETjW2PUt6fspE4scYS_A5iHmYoSKNTShS4TbIPtL2S3zXJd0FdFWehSn4IaoFN-sZbry2Dj5Spv5DGioGXzaVMYZ4fSkGu7PmjeNOOQzHMNcRR5ZKbLRFg5JWKMD1qursZPQLYVb0obPI1U09rTW0OsWMXqPo5HW0oLMNdN7oPN14IlPeuzviMfm89MptdJ4lIR7YsHu8iV5aN8_XbX-a9MCXgFwCnxiAOAk0XxGBmcY4NFHERAq4QqVaWSJZbSKmiJKKyEQEWIQCnEwEPUGZTKIttJgNM72DvJ5hiZI0pEzTOJAyhXJkVEhTE4QiUDV0UX49l1NGcJuYYsALLmPMQVHcKaqGTirRUUGDMU_ouFQhByO1fx5Epof5mLsDshAbUVpD24Vuq8dENLWoBWqfFcqu7ljm6-b7a4MPP_p8nHNsiXBA7nyOXD8fcbjUz_lY8wgzEsKrLlyn_d1g3nh4c4Xd_4seoeVOs8Ufbh_v99CKTT5fbBzbR4uTj1wfAESZ9A6dKX4DNOXd0w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=APOE+and+immunity%3A+Research+highlights&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=Kloske%2C+Courtney+M.&rft.au=Barnum%2C+Christopher+J.&rft.au=Batista%2C+Andre+F.&rft.au=Bradshaw%2C+Elizabeth+M.&rft.date=2023-06-01&rft.issn=1552-5260&rft.eissn=1552-5279&rft.volume=19&rft.issue=6&rft.spage=2677&rft.epage=2696&rft_id=info:doi/10.1002%2Falz.13020&rft.externalDBID=10.1002%252Falz.13020&rft.externalDocID=ALZ13020
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5260&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5260&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5260&client=summon